Drug points: Benign intracranial hypertension secondary to nasal fluticasone propionate

doi:10.1136/bmj.322.7291.897

BMJ 2001;322:897 ( 14 April )

Papers

Drug points

Benign intracranial hypertension secondary to nasal fluticasone propionate

D W Bond, C P J Charlton.

Department of Child Health

R M Gregson.

Department of Ophthalmology, Queen's Medical Centre, University Hospital, Nottingham NG7 2UH
The first 150 words of the full text of this article appear below.

A 13 year old boy with Crohn's disease in remission presented with a 10 day history of head and back pain. He also mentionedintermittent blurring of vision and had developed a new squintfour days before admission. He had a history of hay fever andwas being treated with fluticasone propionate aqueous nasal spray50 µg to each nostril once a day (Glaxo Wellcome). This had beentaken infrequently until five days before admission when our colleaguesfrom the ear, nose, and throat department reviewed him and advisedregulartreatment.

On examination his optic discs were swollen bilaterally and he had a right sixth nerve palsy. Investigations showed no evidenceof intercurrent infection. Urea and electrolytes, liver function,and concentrations of calcium, phosphate, and magnesium were allwithin normal limits. Fluorescein angiography showed leakage ofdye from the optic discs, confirming mild bilateral papilloedema(figure). An unenhanced computed tomogram gave normal results.. . . [Full text of this article]

CiteULike

Complore

Connotea

Del.icio.us Add to Digg

Digg

StumbleUpon Add to Technorati

Technorati What's this?

Relevant Article

Intracranial hypertension and nasal fluticasone propionate: Michael Oko, Andrew Johnston, and Iain R C Swan
BMJ 2001 323: 694. [Extract] [Full Text]

This article has been cited by other articles:

Oko, M., Johnston, A., Swan, I. R C (2001). Intracranial hypertension and nasal fluticasone propionate. BMJ 323: 694-694 [Full text]

Rapid Responses:

Read all Rapid Responses

Caution in blaming nasal steroids in causing 'Benign' intracranial hypertension: Oliver Backhouse
bmj.com, 25 Apr 2001 [Full text]
Drug Points: This is the Weakest Link � goodbye!: Michael Oko, et al.
bmj.com, 1 May 2001 [Full text]